Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis.

MLA

Snijders, Romée J. A. L. M., et al. “Reply to: ‘Correspondence on “Systematic Review of Response Criteria and Endpoints in Autoimmune Hepatitis by the International Autoimmune Hepatitis Group”’: Defining Endpoints That Guide Treatment in Autoimmune Hepatitis.” Journal of Hepatology, vol. 77, no. 5, Nov. 2022, pp. 1464–66. EBSCOhost, https://doi.org/10.1016/j.jhep.2022.07.025.

APA

Snijders, R. J. A. L. M., Gevers, T. J. G., Heneghan, M. A., & Drenth, J. P. H. (2022). Reply to: “Correspondence on ‘Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group’”: Defining endpoints that guide treatment in autoimmune hepatitis. Journal of Hepatology, 77(5), 1464–1466. https://doi.org/10.1016/j.jhep.2022.07.025

Chicago

Snijders, Romée J.A.L.M., Tom J.G. Gevers, Michael A. Heneghan, and Joost P.H. Drenth. 2022. “Reply to: ‘Correspondence on “Systematic Review of Response Criteria and Endpoints in Autoimmune Hepatitis by the International Autoimmune Hepatitis Group”’: Defining Endpoints That Guide Treatment in Autoimmune Hepatitis.” Journal of Hepatology 77 (5): 1464–66. doi:10.1016/j.jhep.2022.07.025.